Research Overview of Ultima-Semaglutide
Ultima-Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Ultima Peptides for advanced laboratory research applications. This synthetic peptide analogue demonstrates high binding affinity for GLP-1 receptors and extended pharmacokinetic properties in preclinical models. Research scientists at Stroid UK Shop can examine this compound’s mechanisms in metabolic regulation studies. The peptide structure incorporates modifications that enhance stability and receptor selectivity compared to native GLP-1, making it valuable for investigating glucose homeostasis pathways and incretin signalling cascades in controlled laboratory environments.
Laboratory Research Applications
Investigators utilise Ultima-Semaglutide to study GLP-1 receptor activation and downstream signalling pathways in various research models. The compound enables examination of glucose-dependent insulin secretion mechanisms, gastric emptying modulation, and appetite regulation circuits. Research applications include investigating pancreatic beta-cell function, hepatic glucose production pathways, and adipose tissue metabolism. Scientists exploring metabolic modulation compounds often incorporate this peptide into comprehensive research protocols. The extended half-life profile allows researchers to evaluate sustained GLP-1 receptor engagement effects. Studies may examine the compound alongside other research chemicals from categories such as SARMs or peptides for comparative metabolic pathway analysis.
Technical Specifications
| Parameter | Value |
|---|---|
| Manufacturer | Ultima Peptides |
| Product Code | EU11817 |
| Molecular Class | GLP-1 Receptor Agonist Peptide |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Storage Requirements | -20°C (lyophilised), 2-8°C (reconstituted) |
| Stability | Use reconstituted solution within 30 days |
Research Compliance Statement
Ultima-Semaglutide from Ultima Peptides is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate laboratory safety protocols and comply with all applicable regulations when handling this research chemical. This product is restricted to qualified research institutions and experienced investigators conducting legitimate scientific studies.
